HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

tetrapotassium pyrophosphate

Networked: 6 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. DeVizio, W: 2 articles (01/2000 - 01/2000)
2. Petrone, M E: 2 articles (01/2000 - 01/2000)
3. Proskin, H M: 2 articles (01/2000 - 01/2000)
4. Volpe, A R: 2 articles (01/2000 - 01/2000)
5. Ballini, A: 1 article (05/2019)
6. Cantore, S: 1 article (05/2019)
7. De Vito, D: 1 article (05/2019)
8. Dipalma, G: 1 article (05/2019)
9. Gargiulo Isacco, C: 1 article (05/2019)
10. Georgakopoulos, P: 1 article (05/2019)

Related Diseases

1. Calculi (Calculus)
05/01/2019 - "The purpose of the present study was to evaluate the anti-calculus efficiency of a mouthwash containing an association of sodium tripolyphosphate, tetrapotassium pyrophosphate, sodium bicarbonate and citric acid in patients affected with gingivitis."
01/01/2000 - "The results of this clinical study support the conclusion that a new calculus-inhibiting dentifrice, containing pyrophosphate, tripolyphosphate and a copolymer in a 0.243% sodium fluoride/silica base, is efficacious for the control of the development of supragingival calculus, and provides a level of benefit greater than that provided by a commercially available calculus-inhibiting dentifrice containing tetrapotassium pyrophosphate, disodium pyrophosphate and tetrasodium pyrophosphate in a 0.243% sodium fluoride/silica base."
01/01/2000 - "The results of this clinical study support the conclusion that a new calculus-inhibiting dentifrice containing pyrophosphate, tripolyphosphate, and a copolymer in a 0.243% sodium fluoride/silica base is efficacious for the control of the development of supragingival calculus, and provides a level of benefit greater than that provided by a commercially available calculus-inhibiting dentifrice containing tetrapotassium pyrophosphate, disodium pyrophosphate, and tetrasodium pyrophosphate in a 0.243% sodium fluoride/silica base."
01/01/2000 - "The objective of this double-blind clinical study, conducted in harmony with the Volpe-Manhold design for studies of dental calculus, was to compare the effect on supragingival calculus formation of a dentifrice containing pyrophosphate, tripolyphosphate and a copolymer in a 0.243% sodium fluoride/silica base (Test Dentifrice), to that of a commercially available calculus-inhibiting dentifrice containing tetrapotassium pyrophosphate, disodium pyrophosphate and tetrasodium pyrophosphate in a 0.243% sodium fluoride/silica base (Positive Control Dentifrice). "
01/01/2000 - "The objective of this double-blind clinical study, conducted in harmony with the Volpe-Manhold design for studies of dental calculus, was to compare the effect on supragingival calculus formation of a dentifrice containing pyrophosphate, tripolyphosphate and a copolymer in a 0.243% sodium fluoride/silica base (Test Dentifrice), to that of a commercially available calculus-inhibiting dentifrice containing tetrapotassium pyrophosphate, disodium pyrophosphate, and tetrasodium pyrophosphate in a 0.243% sodium fluoride/silica base (Positive Control Dentifrice). "
2. Dental Calculus
07/01/1999 - "Tetrasodium and/or tetrapotassium pyrophosphate (Ppi) is the anticalculus component of most tartar control dentifrices on the market today. "
05/01/1997 - "Thirty-eight students were randomly assigned to either the experimental group using a tartar-control dentifrice (containing tetrapotassium pyrophosphate, PEG-6, disodium pyrophosphate, and tetrasodium pyrosulphate in a 5.0% soluble pyrophosphate formulation) or the control group using a regular dentifrice. "
01/01/2003 - "The anticaries properties of a silica-based, sodium fluoride (NaF) toothpaste containing tetrapotassium pyrophosphate (PPi) with anti-tartar properties (Aquafresh All Tartar Control) were assessed in specific pathogen-free Osborne-Mendel rats. "
01/01/2000 - "The objective of this double-blind clinical study, conducted in harmony with the Volpe-Manhold design for studies of dental calculus, was to compare the effect on supragingival calculus formation of a dentifrice containing pyrophosphate, tripolyphosphate and a copolymer in a 0.243% sodium fluoride/silica base (Test Dentifrice), to that of a commercially available calculus-inhibiting dentifrice containing tetrapotassium pyrophosphate, disodium pyrophosphate and tetrasodium pyrophosphate in a 0.243% sodium fluoride/silica base (Positive Control Dentifrice). "
01/01/2000 - "The objective of this double-blind clinical study, conducted in harmony with the Volpe-Manhold design for studies of dental calculus, was to compare the effect on supragingival calculus formation of a dentifrice containing pyrophosphate, tripolyphosphate and a copolymer in a 0.243% sodium fluoride/silica base (Test Dentifrice), to that of a commercially available calculus-inhibiting dentifrice containing tetrapotassium pyrophosphate, disodium pyrophosphate, and tetrasodium pyrophosphate in a 0.243% sodium fluoride/silica base (Positive Control Dentifrice). "
3. Gingivitis

Related Drugs and Biologics

1. triphosphoric acid (triphosphate)
2. Dentifrices (Dentifrice)
3. Sodium Fluoride (Ossin)
4. Silicon Dioxide (Silica)
5. diphosphoric acid (pyrophosphoric acid)
6. sodium pyrophosphate (disodium pyrophosphate)
7. Citric Acid (Citrate)
8. Sodium Bicarbonate (Baking Soda)
9. Toothpastes
10. Aquafresh All Tartar Control